Kirkland & Ellis advised Vitruvian Partners on the deal. Vitruvian Partners announced the formation of Vitruvian Investment Partnership V (VIP V), which recently held its final...
Vitruvian Partners’ €7.3 Billion Vitruvian Investment Partnership V
Silverback Therapeutics’ Merger With ARS Pharmaceuticals
Cooley represented Silverback, Kirkland & Ellis advised Nextech, Inceptiv Law advised ARS on the deal. Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”) and ARS Pharmaceuticals, Inc. (“ARS”)...
Ares Capital Europe V’s €11.0 Billion Fundraising
Kirkland & Ellis advised Ares Management Corporation on the deal. Ares Management Corporation (“Ares”) (NYSE: ARES), a leading global alternative investment manager, closed its fifth commingled...